Prosecution Insights
Prosecution Insights
Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials
2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready
Enzyre B V is active in the Chemistry & Materials technology area. The company currently has 2 pending office actions. These actions are divided between 2 distinct examiners and 2 distinct art units. This distribution suggests that the company's current patent applications cover diverse technical aspects within the chemistry domain.
The busiest examiner for this portfolio is MUTREJA, JYOTI NAGPAUL. This examiner is responsible for 1 pending office action. With 2 pending office actions and 2 distinct examiners, the workload is split evenly. Each examiner handles 1 pending action in their respective art unit. This means that the company's prosecution efforts are not centralized under a single individual or art unit. Instead, the 2 pending office actions are being reviewed by 2 distinct examiners across 2 distinct art units. This decentralized approach requires the company to manage multiple examination tracks simultaneously, as each of the 2 pending office actions is subject to independent review by different examiners.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Double-patenting + other | 1 (50%) |
| Multi-statute (no §101) | 1 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| MUTREJA, JYOTI NAGPAUL | 1 | 81.0% | +4.0% |
| KOMATSU, LI N | 1 | 59.8% | +71.1% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18276924 | Pressure Driven Microfluidic Chip And Method For Delivering A Sample At A Determined Flow Rate | MUTREJA, JYOTI NAGPAUL | 19d overdue |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17285098 | Novel chemiluminescent substrates for Factor Xa | KOMATSU, LI N | — |
| Art Unit | Apps |
|---|---|
| 1798 | 1 |
| 1658 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18276924 | Pressure Driven Microfluidic Chip And Method For Delivering A Sample At A Determined Flow Rate | MUTREJA, JYOTI NAGPAUL | 1798 | §102§103§112 | Final Rejection | 19d overdue | Pending | Aug 11, 2023 |
| 17285098 | Novel chemiluminescent substrates for Factor Xa | KOMATSU, LI N | 1658 | §103DP | Non-Final OA | — | Pending | Apr 14, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial